Page last updated: 2024-11-11

brl 37344

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BRL 37344: SB 206606 is the (R,R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9841972
CHEMBL ID284782
CHEBI ID131180
SCHEMBL ID304308
MeSH IDM0160571

Synonyms (40)

Synonym
2-[4-[(2r)-2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid
gtpl567
brl37344
sb 206606
brl-37344
acetic acid, (4-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-
brl 37344
sb-206606
2-(4-((2r)-2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
CHEMBL284782 ,
114333-71-0
(brl 37,344)(4-{2-[2-(3-chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid
(4-{2-[(r)-2-((r)-3-chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid
(+/-)-2-(4-((r)-2-((r)-2-(3-chlorophenyl)-2-hydroxyethylamino)propyl)phenoxy)acetic acid
2-(4-((r)-2-((r)-2-(3-chlorophenyl)-2-hydroxyethylamino)propyl)phenoxy)acetic acid
(4-{2-[2-(3-chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid
(4-{(r)-2-[(r)-2-(3-chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid
(r*, r*) (4-{2-[2-(3-chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid
bdbm50002133
CHEBI:131180
5dzz1926yw ,
unii-5dzz1926yw
BRD-K07507905-236-01-8
acetic acid, (4-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-, (r*,r*)-(+/-)-
SCHEMBL304308
brl-44092
(4-((2r)-2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
acetic acid, (4-((2r)-2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-
42FZ27IZLV ,
acetic acid, 2-(4-((2r)-2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-
883868-48-2
unii-42fz27izlv
116049-78-6
(4-((2r)-2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino}propyl)phenoxy)acetic acid
Q27075510
HY-117239
CS-0064501
acetic acid, 2-[4-[(2r)-2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]-
DTXSID101126185
AKOS040753946

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pretreatment with BRL 37344 induced a marked desensitization of the distal colon and fundic strips but not the aorta and carotid artery to isoprenaline."( Different atypical beta-adrenoceptors mediate isoprenaline-induced relaxation in vascular and non-vascular smooth muscles.
Oriowo, MA, 1995
)
0.61

Dosage Studied

ExcerptRelevanceReference
" The pA2 values of the beta adrenergic antagonists propranolol, metoprolol and atenolol were calculated from the rightward shifts that they impose on dose-response curves of both l-isoproterenol and CGP12177."( Multiple beta adrenergic receptor subclasses mediate the l-isoproterenol-induced lipolytic response in rat adipocytes.
Van Liefde, I; Van Witzenburg, A; Vauquelin, G, 1992
)
0.28
" Dose-response curves show similar sensitivity, but decreased responsiveness in the lean animal."( Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists.
Bray, GA; Tsujii, S, 1992
)
0.28
" AC dose-response curves were obtained by incubating membrane fractions with different concentrations of isoproterenol and BRL37344 (1 nM-100 microM) at 25 degrees C for 15 min."( [Adenylate cyclase response to beta-adrenergic agonists in heart and brown adipose tissue].
Cignarelli, M; De Pergola, G; Garruti, G; Giorgino, R; Stock, M,
)
0.13
" Dose-response curves for oxygen consumption and brown adipose tissue temperature were identical, whichever of the beta-adrenoceptor agonists was used."( The beta-adrenoceptor selectivity profile of BRL 37344 in the pithed rat.
Cawthorne, MA; Oriowo, MA; Ruffolo, RR; Sennitt, MV; Smith, SA, 1994
)
0.55
" Concentration-response curves for activation of lipolysis by each agonist correlated well with the dose-response curves for activation of cAMP-dependent protein kinase (A-Kinase)."( Correlation of beta 3-adrenoceptor-induced activation of cyclic AMP-dependent protein kinase with activation of lipolysis in rat white adipocytes.
Cawthorne, MA; Kirkham, DM; Murphy, GJ; Young, P, 1993
)
0.29
" The BRL37344 dose-response curve was not altered by nadolol (10(-5) M), a potent beta1- and beta2-AR antagonist, but completely suppressed by bupranolol (10(-6) M), a potent beta1-, beta2- and beta3-AR antagonist."( The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart.
Dohi, K; Isaka, N; Kitamura, T; Nakano, T; Okinaka, T; Onishi, K, 2000
)
0.31
"The effect of dietary olive oil and fish oil on the lipolytic dose-response of the beta3-adrenergic agonists, epinephrine, isoproterenol, BRL-37344, and CGP-12177, in adipocytes was studied in pregnant and virgin rats either untreated or under hyperinsulinemic-euglycemic conditions."( Changes in dietary fatty acids modify the decreased lipolytic beta3-adrenergic response to hyperinsulinemia in adipocytes from pregnant and nonpregnant rats.
Amusquivar, E; Cacho, J; Herrera, E, 2000
)
0.31
" The dose-response relationships of the beta(3)-adrenoceptor agonists were challenged with the selective beta(3)-adrenoceptor antagonist 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) or the beta(2)-adrenoceptor antagonist (-)propranolol."( Enhancement of memory consolidation in chicks by beta(3)-adrenoceptor agonists.
Gibbs, ME; Summers, RJ, 2001
)
0.31
" Insulin responsiveness of the lipolytic and lipogenic pathways was analyzed by dose-response experiments, giving evidence for the involvement of improved insulin responsiveness in the enhanced lipogenic and reduced lipolytic activities of adipocytes in early pregnancy."( Fat accumulation in the rat during early pregnancy is modulated by enhanced insulin responsiveness.
Cacho, J; Crespo-Solans, MD; del Campo, S; Herrera, E; Ramos, MP, 2003
)
0.32
" The BRL37344 dose-response curves were not altered by nadolol (10(-5) mol/L), a potent beta(1)- and beta(2)-AR antagonist, but were completely suppressed by the addition of SR59230A (10(-5) mol/L), a potent beta(3)-AR antagonist."( Existence of beta(3)-adrenoceptors in rat heart: functional implications.
Barbier, J; Carré, F; Mouas, C; Rannou-Bekono, F, 2007
)
0.34
" The administration of progesterone had no effect on the beta(3)-AR mRNA and protein expression or the maximum relaxation effect of BRL 37344, but shifted the dose-response curve to the right and decreased the synthesis of the second messenger, cAMP."( Progesterone decreases the relaxing effect of the beta3-adrenergic receptor agonist BRL 37344 in the pregnant rat myometrium.
Falkay, G; Gál, A; Gáspár, R; Klukovits, A; Minorics, R, 2009
)
0.78
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (15)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-2 adrenergic receptorHomo sapiens (human)IC50 (µMol)3.00000.00020.93267.2000AID41178
Beta-2 adrenergic receptorHomo sapiens (human)Ki2.85000.00000.66359.5499AID287726
Beta-1 adrenergic receptorHomo sapiens (human)IC50 (µMol)5.00000.00021.46819.0000AID40244
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)IC50 (µMol)0.86970.00301.17839.7724AID220923; AID41471
Beta-3 adrenergic receptorHomo sapiens (human)Ki0.66000.00302.30986.0450AID41509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-2 adrenergic receptorHomo sapiens (human)EC50 (µMol)0.29000.00000.311110.0000AID1095331; AID41032
Gamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Gamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Beta-1 adrenergic receptorHomo sapiens (human)EC50 (µMol)1.70000.00010.49146.0000AID1095332; AID40110
Gamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Gamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Beta-3 adrenergic receptorHomo sapiens (human)EC50 (µMol)0.10590.00010.455310.0000AID1095329; AID326592; AID326595; AID41512; AID41634; AID41656; AID41667; AID41668; AID41938
Gamma-aminobutyric acid receptor subunit alpha-4Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Gamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)EC50 (µMol)0.45000.00040.22520.4500AID41667
Alpha-1D adrenergic receptorHomo sapiens (human)EC50 (µMol)5.60000.00151.72275.6000AID220909
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)EC50 (µMol)0.00110.00010.71753.0000AID220925; AID41938
Alpha-1A adrenergic receptorHomo sapiens (human)EC50 (µMol)5.60000.00010.50987.1000AID220909
Alpha-1B adrenergic receptorHomo sapiens (human)EC50 (µMol)5.60000.00011.30105.6000AID220909
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)EC20 (µMol)0.12000.00020.06010.1200AID40397
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (78)

Processvia Protein(s)Taxonomy
diet induced thermogenesisBeta-2 adrenergic receptorHomo sapiens (human)
regulation of sodium ion transportBeta-2 adrenergic receptorHomo sapiens (human)
transcription by RNA polymerase IIBeta-2 adrenergic receptorHomo sapiens (human)
receptor-mediated endocytosisBeta-2 adrenergic receptorHomo sapiens (human)
smooth muscle contractionBeta-2 adrenergic receptorHomo sapiens (human)
cell surface receptor signaling pathwayBeta-2 adrenergic receptorHomo sapiens (human)
activation of transmembrane receptor protein tyrosine kinase activityBeta-2 adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayBeta-2 adrenergic receptorHomo sapiens (human)
endosome to lysosome transportBeta-2 adrenergic receptorHomo sapiens (human)
response to coldBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of protein kinase A signalingBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of bone mineralizationBeta-2 adrenergic receptorHomo sapiens (human)
heat generationBeta-2 adrenergic receptorHomo sapiens (human)
negative regulation of multicellular organism growthBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeBeta-2 adrenergic receptorHomo sapiens (human)
bone resorptionBeta-2 adrenergic receptorHomo sapiens (human)
negative regulation of G protein-coupled receptor signaling pathwayBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIBeta-2 adrenergic receptorHomo sapiens (human)
negative regulation of smooth muscle contractionBeta-2 adrenergic receptorHomo sapiens (human)
brown fat cell differentiationBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of mini excitatory postsynaptic potentialBeta-2 adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayBeta-2 adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of cold-induced thermogenesisBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of autophagosome maturationBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of lipophagyBeta-2 adrenergic receptorHomo sapiens (human)
cellular response to amyloid-betaBeta-2 adrenergic receptorHomo sapiens (human)
response to psychosocial stressBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of cAMP-dependent protein kinase activityBeta-2 adrenergic receptorHomo sapiens (human)
positive regulation of AMPA receptor activityBeta-2 adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressureBeta-2 adrenergic receptorHomo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
monoatomic ion transportGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
positive regulation of heart rate by epinephrine-norepinephrineBeta-1 adrenergic receptorHomo sapiens (human)
positive regulation of the force of heart contraction by epinephrine-norepinephrineBeta-1 adrenergic receptorHomo sapiens (human)
diet induced thermogenesisBeta-1 adrenergic receptorHomo sapiens (human)
response to coldBeta-1 adrenergic receptorHomo sapiens (human)
heat generationBeta-1 adrenergic receptorHomo sapiens (human)
negative regulation of multicellular organism growthBeta-1 adrenergic receptorHomo sapiens (human)
fear responseBeta-1 adrenergic receptorHomo sapiens (human)
regulation of circadian sleep/wake cycle, sleepBeta-1 adrenergic receptorHomo sapiens (human)
brown fat cell differentiationBeta-1 adrenergic receptorHomo sapiens (human)
regulation of postsynaptic membrane potentialBeta-1 adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayBeta-1 adrenergic receptorHomo sapiens (human)
positive regulation of cold-induced thermogenesisBeta-1 adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressureBeta-1 adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeBeta-1 adrenergic receptorHomo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)
receptor-mediated endocytosisBeta-3 adrenergic receptorHomo sapiens (human)
negative regulation of G protein-coupled receptor signaling pathwayBeta-3 adrenergic receptorHomo sapiens (human)
diet induced thermogenesisBeta-3 adrenergic receptorHomo sapiens (human)
carbohydrate metabolic processBeta-3 adrenergic receptorHomo sapiens (human)
generation of precursor metabolites and energyBeta-3 adrenergic receptorHomo sapiens (human)
energy reserve metabolic processBeta-3 adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerBeta-3 adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayBeta-3 adrenergic receptorHomo sapiens (human)
response to coldBeta-3 adrenergic receptorHomo sapiens (human)
heat generationBeta-3 adrenergic receptorHomo sapiens (human)
negative regulation of multicellular organism growthBeta-3 adrenergic receptorHomo sapiens (human)
eating behaviorBeta-3 adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeBeta-3 adrenergic receptorHomo sapiens (human)
brown fat cell differentiationBeta-3 adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayBeta-3 adrenergic receptorHomo sapiens (human)
positive regulation of cold-induced thermogenesisBeta-3 adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressureBeta-3 adrenergic receptorHomo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-1D adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1D adrenergic receptorHomo sapiens (human)
MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of heart rate by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of the force of heart contraction by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
apoptotic processAlpha-1A adrenergic receptorHomo sapiens (human)
smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
activation of phospholipase C activityAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1A adrenergic receptorHomo sapiens (human)
adult heart developmentAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of cell population proliferationAlpha-1A adrenergic receptorHomo sapiens (human)
response to xenobiotic stimulusAlpha-1A adrenergic receptorHomo sapiens (human)
response to hormoneAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of autophagyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle hypertrophyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of action potentialAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
calcium ion transport into cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
cell growth involved in cardiac muscle cell developmentAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of protein kinase C signalingAlpha-1A adrenergic receptorHomo sapiens (human)
pilomotor reflexAlpha-1A adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-1B adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of cardiac muscle contractionAlpha-1B adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1B adrenergic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
amyloid-beta bindingBeta-2 adrenergic receptorHomo sapiens (human)
beta2-adrenergic receptor activityBeta-2 adrenergic receptorHomo sapiens (human)
protein bindingBeta-2 adrenergic receptorHomo sapiens (human)
adenylate cyclase bindingBeta-2 adrenergic receptorHomo sapiens (human)
potassium channel regulator activityBeta-2 adrenergic receptorHomo sapiens (human)
identical protein bindingBeta-2 adrenergic receptorHomo sapiens (human)
protein homodimerization activityBeta-2 adrenergic receptorHomo sapiens (human)
protein-containing complex bindingBeta-2 adrenergic receptorHomo sapiens (human)
norepinephrine bindingBeta-2 adrenergic receptorHomo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
ligand-gated monoatomic ion channel activityGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
beta-adrenergic receptor activityBeta-1 adrenergic receptorHomo sapiens (human)
beta1-adrenergic receptor activityBeta-1 adrenergic receptorHomo sapiens (human)
protein bindingBeta-1 adrenergic receptorHomo sapiens (human)
PDZ domain bindingBeta-1 adrenergic receptorHomo sapiens (human)
alpha-2A adrenergic receptor bindingBeta-1 adrenergic receptorHomo sapiens (human)
protein heterodimerization activityBeta-1 adrenergic receptorHomo sapiens (human)
G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potentialBeta-1 adrenergic receptorHomo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)
norepinephrine bindingBeta-3 adrenergic receptorHomo sapiens (human)
beta-adrenergic receptor activityBeta-3 adrenergic receptorHomo sapiens (human)
protein bindingBeta-3 adrenergic receptorHomo sapiens (human)
beta3-adrenergic receptor activityBeta-3 adrenergic receptorHomo sapiens (human)
beta-3 adrenergic receptor bindingBeta-3 adrenergic receptorHomo sapiens (human)
protein homodimerization activityBeta-3 adrenergic receptorHomo sapiens (human)
epinephrine bindingBeta-3 adrenergic receptorHomo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
identical protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1D adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1B adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1B adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1B adrenergic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
nucleusBeta-2 adrenergic receptorHomo sapiens (human)
lysosomeBeta-2 adrenergic receptorHomo sapiens (human)
endosomeBeta-2 adrenergic receptorHomo sapiens (human)
early endosomeBeta-2 adrenergic receptorHomo sapiens (human)
Golgi apparatusBeta-2 adrenergic receptorHomo sapiens (human)
plasma membraneBeta-2 adrenergic receptorHomo sapiens (human)
endosome membraneBeta-2 adrenergic receptorHomo sapiens (human)
membraneBeta-2 adrenergic receptorHomo sapiens (human)
apical plasma membraneBeta-2 adrenergic receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneBeta-2 adrenergic receptorHomo sapiens (human)
neuronal dense core vesicleBeta-2 adrenergic receptorHomo sapiens (human)
receptor complexBeta-2 adrenergic receptorHomo sapiens (human)
plasma membraneBeta-2 adrenergic receptorHomo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)
plasma membraneGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
postsynaptic membraneGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)
early endosomeBeta-1 adrenergic receptorHomo sapiens (human)
plasma membraneBeta-1 adrenergic receptorHomo sapiens (human)
Schaffer collateral - CA1 synapseBeta-1 adrenergic receptorHomo sapiens (human)
neuronal dense core vesicleBeta-1 adrenergic receptorHomo sapiens (human)
plasma membraneBeta-1 adrenergic receptorHomo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)
postsynaptic membraneGamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)
postsynaptic membraneGamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)
plasma membraneBeta-3 adrenergic receptorHomo sapiens (human)
receptor complexBeta-3 adrenergic receptorHomo sapiens (human)
plasma membraneBeta-3 adrenergic receptorHomo sapiens (human)
postsynaptic membraneGamma-aminobutyric acid receptor subunit alpha-4Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-4Bos taurus (cattle)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
nucleusAlpha-1A adrenergic receptorHomo sapiens (human)
nucleoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
caveolaAlpha-1A adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular membrane-bounded organelleAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
nucleusAlpha-1B adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
caveolaAlpha-1B adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (51)

Assay IDTitleYearJournalArticle
AID233229Concentration ratio of beta-1 (EC50) to beta3 (EC50)2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID41032Agonistic activity against human Beta-2 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41656Agonism of recombinant human beta-3 adrenergic receptor assayed by measuring cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41484Agonistic activity for Beta-2 adrenergic receptor was assessed by it's inhibitory effect on spontaneous contractions in isolated rat uterus2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID41189Agonistic activity against human Beta-2 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41471Compound was evaluated for its binding affinity towards Beta-2 adrenergic receptor in rat soleus membrane by displacing (-)-isoproterenol (50 uM)1992Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.
AID41510Human beta-3 adrenergic receptor agonist activity by measurement of cAMP accumulation levels in CHO membranes expressing human beta-3 receptor.2001Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
Beta 3 agonists. Part 1: evolution from inception to BMS-194449.
AID326592Agonist activity at human adrenergic beta-3 receptor expressed in CHO cells assessed as cAMP levels by DELFIA method2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
AID41512Concentration required to effect a 50% relaxation of ferret detrusor basal tone2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID41940In vitro beta-adrenergic activity against beta-3 adrenergic receptor in rat epididymal fat pads by stimulation of glycerol release from adipocytes.1992Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.
AID220925Agonistic activity towards beta-3 adrenoceptor. Mean concentration required to produce 50% relaxation of detrusor before the addition in the ferret detrusor2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID40401Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol1992Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.
AID230167The intrinsic activity is given as the ratio of the maximum stimulation with forskolin (10e-5 M)2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID220911In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle1992Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.
AID1095332Agonist activity at Homo sapiens (human) beta1 adrenoreceptor2010Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Dec, Volume: 19, Issue:9
Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.
AID42061Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41938Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41178Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
AID41634Agonistic activity for Beta-3 adrenergic receptor as relaxing ability of isolated ferret detrusor basal tone2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID1095329Agonist activity at Homo sapiens (human) beta3 adrenoreceptor2010Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Dec, Volume: 19, Issue:9
Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.
AID220923Agonistic activity towards beta-2 adrenoceptor. Mean concentration required to produce 50% inhibition of uterine contraction2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID1095330Agonist activity at Homo sapiens (human) beta3 adrenoreceptor relative to control2010Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Dec, Volume: 19, Issue:9
Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.
AID326595Agonist activity at human adrenergic beta3 receptor expressed in CHO cells assessed as [3H]cAMP levels by radiolabeled ligand based assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
AID40683Selectivity as the ratio of Ki of beta-2 adrenergic receptor to the Ki of beta-3 adrenergic receptor.2001Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
Beta 3 agonists. Part 1: evolution from inception to BMS-194449.
AID40110Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID234917Selectivity for beta3-AR over beta2-AR was determined2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID40529Agonistic activity for Beta-1 adrenergic receptor was estimated from it's chronotropic effect on rat atria2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID220927Activity compared to that observed following forskolin (10e -5).2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID326593Intrinsic activity at human adrenergic beta-3 receptor expressed in CHO cells assessed as cAMP levels relative to R-(-)-isoproterenol2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
AID234915Selectivity for beta3-AR over beta1-AR was determined2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID220913Increase in BPM in isolated rat atria.2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID42021Selectivity measured as the ratio of Ki of Beta-1 Adrenergic receptor to the Ki of Beta-3 Adrenergic receptor2001Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
Beta 3 agonists. Part 1: evolution from inception to BMS-194449.
AID41474Inhibition of spontaneous contractions in isolated rat uterus2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID233231Concentration ratio of beta-2 (EC50) to beta3 (EC50)2001Journal of medicinal chemistry, Apr-26, Volume: 44, Issue:9
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
AID1095331Agonist activity at Homo sapiens (human) beta2 adrenoreceptor2010Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, Dec, Volume: 19, Issue:9
Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.
AID40244Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
AID41668Compound was evaluated for agonistic activity in human Beta-3 adrenergic receptor assay; partial weak agonist1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
AID287726Displacement of [125I]CYP from human adrenergic beta 2 receptor transfected in CHO cells in presence of 100 uM GTP2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypes.
AID40258Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID41509Binding affinity against CHO cells transfected with human beta-3 adrenergic receptor in the presence of [125I]iodocyanopindolol2001Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
Beta 3 agonists. Part 1: evolution from inception to BMS-194449.
AID220909In vitro beta-adrenergic activity against beta-1 adrenergic receptor by stimulation of rate of contraction of guinea pig atria1992Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.
AID41648Agonism of human beta-3 adrenergic receptor1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
AID40397Mean concentration required to increase basal rate of rat atria by 20 beats per minute2003Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
AID41667Agonism against Beta-3 adrenergic receptor1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.
AID41803Agonistic activity to recombinant human beta-3 adrenergic receptor expressed in CHO cells by measuring cAMP accumulation2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.
AID1346297Human beta3-adrenoceptor (Adrenoceptors)1995European journal of pharmacology, Nov-30, Volume: 291, Issue:3
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
AID1346297Human beta3-adrenoceptor (Adrenoceptors)2004Naunyn-Schmiedeberg's archives of pharmacology, Feb, Volume: 369, Issue:2
Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.
AID1346297Human beta3-adrenoceptor (Adrenoceptors)1994The Journal of pharmacology and experimental therapeutics, Jun, Volume: 269, Issue:3
Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.
AID1346312Mouse beta3-adrenoceptor (Adrenoceptors)1995European journal of pharmacology, Nov-30, Volume: 291, Issue:3
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
AID1347018Rat beta3-adrenoceptor (Adrenoceptors)1995European journal of pharmacology, Nov-30, Volume: 291, Issue:3
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
AID1346297Human beta3-adrenoceptor (Adrenoceptors)1993Molecular pharmacology, Dec, Volume: 44, Issue:6
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (284)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (0.70)18.7374
1990's128 (45.07)18.2507
2000's99 (34.86)29.6817
2010's51 (17.96)24.3611
2020's4 (1.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.03 (24.57)
Research Supply Index5.67 (2.92)
Research Growth Index6.91 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (0.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other288 (99.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]